GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HT942525CE039INHALON BIOPHARMA, INC.

Overview

Award facts

Net obligations
$3.18M
$3,175,643of $3.18M potential value
Period of performance
Sep 22, 2025 to Dec 31, 2027
Ends in 13 months
Modifications
0
Latest action Sep 22, 2025
Contract type
Definitive contract
PIID HT942525CE039

Description of requirement

A PHASE 1 PLACEBO-CONTROLLED DOSE-ESCALATION SAFETY AND PHARMACOKINETIC STUDY OF IN-007, A NEBULIZED, PAN-SARS ACE2-DECOY THERAPEUTIC FOR PANDEMIC PREPAREDNESS

Dates and value

Award date
Signed on Sep 22, 2025
Potential end of performance
Dec 30, 2027
Current value
$3,175,643Base and exercised options
Potential value (if all options are exercised)
$3,175,643

Obligations by fiscal year of action

  • FY2025: $3,175,643

Total across 1 fiscal year: $3,175,643

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 12, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 22, 2025. View on USAspending · Recipient on SAM.gov

Recipient

NameINHALON BIOPHARMA, INC.
LocationMORRISVILLE, NC
UEIHFQSJ2GMNRU6
CAGE code87U21
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyINHALON BIOPHARMA, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Defense
  2. Defense Health Agency
  3. ARMY MED RES ACQ ACTIVITY
Funded by
  1. Department of Defense
  2. Defense Health Agency
  3. CONG DIR MED RES PRGM / CDMRP - MM

Place of performance

Place of performance
Morrisville, Wake County, North Carolina 27560-8425
Congressional district (place of performance)
NC-04As reported at the time of the action

Classification and competition

Classification

NAICS
541715RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product or service (PSC)
AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Fixed price level of effortB
Offers received
44

Solicitation and notices

Solicitation ID
HT942524SJWMR(as reported)
Solicitation date
Apr 17, 2024

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 22, 2025Base obligation at award: $3,175,643
Latest action
Sep 22, 2025 — Base awardModification 0; obligation change +$3,175,643
Actions by type
  • Base award1
1 actions recorded, Sep 22, 2025 to Sep 22, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$3,175,643
Latest action: change in base and all options
$3,175,643

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase iii actionSR3

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
IT commercial item category
Not IT products or servicesZ
Awarding agency code
9700
Awarding sub-tier code
97DH
Contracting office code
HT9425
Transactions recorded under this award key
1

Funding

Funding agency code
9700
Funding sub-tier code
97DH
Funding office code
HT0989